Your browser doesn't support javascript.
loading
Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.
Lutz, Sebastian; Klausz, Katja; Albici, Anca-Maria; Ebinger, Lea; Sellmer, Lea; Teipel, Hannah; Frenzel, André; Langner, Anna; Winterberg, Dorothee; Krohn, Steffen; Hust, Michael; Schirrmann, Thomas; Dübel, Stefan; Scherließ, Regina; Humpe, Andreas; Gramatzki, Martin; Kellner, Christian; Peipp, Matthias.
Afiliação
  • Lutz S; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, Ludwig Maximilians University (LMU) Munich, Munich, Germany.
  • Klausz K; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Albici AM; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Ebinger L; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Sellmer L; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Teipel H; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Frenzel A; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Langner A; YUMAB GmbH, Braunschweig, Germany.
  • Winterberg D; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Krohn S; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Hust M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
  • Schirrmann T; YUMAB GmbH, Braunschweig, Germany.
  • Dübel S; Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Braunschweig, Germany.
  • Scherließ R; YUMAB GmbH, Braunschweig, Germany.
  • Humpe A; Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Braunschweig, Germany.
  • Gramatzki M; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
  • Kellner C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, Ludwig Maximilians University (LMU) Munich, Munich, Germany.
  • Peipp M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University, Kiel, Germany.
Front Immunol ; 14: 1227572, 2023.
Article em En | MEDLINE | ID: mdl-37965326
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Linfoma / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Linfoma / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article